Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs RYHIX overlap: 79% of top holdings shared

Bottom line

How much do XLV and RYHIX overlap?

79% of their top holdings overlap by weight. 23 securities appear in both funds' top 25, making up 83.0% of XLV's assets and 34.7% of RYHIX's. They are largely the same portfolio — owning both adds little diversification.

RYHIX holds far more positions (135 vs 65), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

XLVRYHIX
Weight overlap (top 25)79%
Shared holdings23
Weight in shared holdings83.0%34.7%
Total positions65135
Expense ratio0.08%1.38%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings XLV and RYHIX have in common

Holding% of XLV% of RYHIXOverlap
Eli Lilly & Co16.51%3.63%3.63%
Johnson & Johnson10.64%2.88%2.88%
AbbVie Inc7.74%2.52%2.52%
UnitedHealth Group Inc6.57%2.22%2.22%
Merck & Co Inc5.52%2.04%2.04%
Amgen Inc3.40%1.56%1.56%
Thermo Fisher Scientific Inc3.24%1.61%1.61%
Abbott Laboratories2.75%1.42%1.42%
Gilead Sciences Inc2.73%1.39%1.39%
Intuitive Surgical Inc2.45%1.31%1.31%
Pfizer Inc2.39%1.25%1.25%
CVS Health Corp2.30%1.31%1.31%
Vertex Pharmaceuticals Inc2.19%1.34%1.34%
Danaher Corp2.09%1.30%1.30%
Bristol-Myers Squibb Co2.05%1.22%1.22%
Stryker Corp1.89%1.21%1.21%
McKesson Corp1.58%1.05%1.05%
Elevance Health Inc1.46%1.02%1.02%
Cigna Group/The1.27%0.94%0.94%
Boston Scientific Corp1.10%0.86%0.86%
Regeneron Pharmaceuticals Inc1.08%0.90%0.90%
HCA Healthcare Inc1.05%0.87%0.87%
Cardinal Health Inc0.97%0.86%0.86%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. Medtronic PLC — 1.75%
  2. Cencora Inc — 0.96%

Only in RYHIX

  1. Edwards Lifesciences Corp — 0.84%
  2. Novo Nordisk A/s — 0.83%

Asset mix

Asset typeXLVRYHIX
Stocks99.7%83.2%
Repurchase agreements—0.9%
Cash & short-term funds0.3%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryXLVRYHIX
US97.9%73.0%
IE2.1%3.3%
CH—2.3%
GB—1.8%
DK—1.4%
NL—0.7%
IL—0.6%
DE—0.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do XLV and RYHIX overlap?
About 79% by weight. 23 securities appear in both funds' top 25 holdings; they make up 83.0% of XLV's assets and 34.7% of RYHIX's. They are largely the same portfolio — owning both adds little diversification.
What stocks do XLV and RYHIX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, AbbVie Inc, UnitedHealth Group Inc, Merck & Co Inc.
Should I own both XLV and RYHIX?
Owning both adds little diversification: most of their top holdings are the same, so most investors pick one — often the one with the lower expense ratio.
Which holds more stocks, XLV or RYHIX?
RYHIX is broader, with 135 positions versus 65 for XLV. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.